Phosphorylated p27Kip1 on Thr157 is an important prognosis in human hepatocellular carcinoma in vivo and in vitro.

Medical Oncology
Song HeAiguo Shen

Abstract

The p27(Kip1) cyclin-dependent kinase inhibitor is a negative regulator of cell cycle progression in G(1) phase; recent studies suggested that oncogenically activated kinase Akt/PKB can also phosphorylate p27(kip1) at T157 inducing its relocalization to the cytoplasm. To evaluate the significance of p-p27 Thr157 and PI3K pathway in hepatocellular carcinoma (HCC), we studied 51 hepatocellular carcinomas along with corresponding nontumoral tissue and the HCC cell lines. Immunohistochemistry and western blot analysis suggested that p-p27 Thr157 was overexpressed in HCC, which was positively correlated with proliferation marker Ki-67. Correlation analysis was performed among immunohistochemistry-assessed level of p-p27 Thr157, survival, and major clinical and pathological variables. Overexpressed p-p27 Thr157 was correlated with histological differentiation (P < 0.05). Univariate analysis showed that p-p27 Thr157 and Ki-67 expression were correlated with tumor-specific survival. In a multivariate analysis, p-p27 Thr157 and Ki-67 protein expression were proved to be an independent prognostic for HCC. While in vitro, treatment of LY294002 and transduction of mutant p27 (T157A) could diminish the expression of p-p27 Thr157 protein and...Continue Reading

References

Oct 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·J Q ChengJ R Testa
Apr 20, 1990·Cell·A Ullrich, J Schlessinger
Feb 21, 1997·Cell·T F FrankeL C Cantley
Mar 7, 1997·The Journal of Biological Chemistry·M P DermanL G Cantley
Jun 1, 1997·Nature Medicine·M MoriT Akiyoshi
Oct 22, 1998·The British Journal of Surgery·E A AkriviadisW C Meyers
Dec 23, 1998·Proceedings of the National Academy of Sciences of the United States of America·T SoucekM Hengstschläger
Feb 23, 1999·The American Journal of Pathology·R V LloydB W Scheithauer
Jul 1, 1999·Genes & Development·C J Sherr, J M Roberts
Oct 8, 1999·The Journal of Clinical Investigation·G BaldassarreG Viglietto
Mar 4, 2000·The Biochemical Journal·B Vanhaesebroeck, D R Alessi
Mar 4, 2000·Journal of Cellular Physiology·J Slingerland, M Pagano
Mar 4, 2000·Journal of Cellular Physiology·A SgambatoI B Weinstein
Jun 4, 2002·The Journal of Biological Chemistry·Naoya FujitaTakashi Tsuruo
Sep 24, 2002·Nature Medicine·Jiyong LiangJoyce M Slingerland
Jan 28, 2003·Cell Cycle·Giuseppe VigliettoAlfredo Fusco
Mar 7, 2003·Cancer Cell·Stacy W BlainAndrew Koff
Mar 31, 2004·Cancer Cell·Jordi BruixJosep M Llovet
Apr 21, 2006·The Journal of Pharmacology and Experimental Therapeutics·Andres A Caro, Arthur I Cederbaum
Jul 30, 2008·Archives of Medical Research·Mudan LuAiguo Shen

❮ Previous
Next ❯

Citations

Dec 20, 2013·International Journal of Molecular Sciences·Yasunobu MatsudaMasayuki Kubota

❮ Previous
Next ❯

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.